Skip to content

The Bowdoin Group Completes Commercial Expansion for AMAG

Posted by Lauren Kendall on June 20, 2017
WALTHAM, Mass., June 20, 2017 – The Bowdoin Group, a specialized executive search firm focused on C-Suite and strategic build-outs for companies from start-up through rapid expansion, announced today that it has completed a large-scale national commercial expansion in partnership with its client, AMAG Pharmaceuticals, Inc.  AMAG is a leading biopharmaceutical company focused on developing and delivering important therapeutics and research in areas of unmet need such as maternal and women’s health, anemia management, and cancer care.

Recruiting began after AMAG acquired the U.S. commercial rights to Intrarosa™, an FDA-approved product for the treatment of moderate to severe dyspareunia (pain during intercourse).  This acquisition required the creation of a new Women’s Health division within AMAG.  Bowdoin was chosen because of its deep expertise in the Biopharmaceutical industry and its unique ability to hire at the executive level and to build out commercial teams.  Together with the AMAG team, Bowdoin hired 165 exceptional candidates as Area Executive Directors, Regional Sales Directors, Specialty Account Representatives, Managed Care, and Marketing leadership in just four short months.

Executive Director of Human Resources at AMAG, Barry Rubenstein, describes the high level of service Bowdoin provided during this extensive project. “This expansion could not have been possible without Bowdoin,” said Rubenstein, “Bowdoin seamlessly integrated with AMAG’s leadership team to help us hire excellent talent for our new division. In addition to leading all sourcing and recruiting efforts, Bowdoin provided logistical support for the interview process, which included scheduling, making travel arrangements, and coordinating recruiting events across the country, which allowed our team to solely focus on meeting the best candidates in the talent pool.”

In regards to this recent success, The Bowdoin Group Founder and CEO, David Melville, commented, “AMAG is ambitiously growing, and we’re thrilled to have been a part of building their Women’s Health division—the team is going to do great things. This project required flawless execution to meet the tight time frame between AMAG’s acquisition of Intrarosa and the expected commercialization of the product.  Being part of building this division from its inception was a privilege, and we’re excited to see what its future holds.”

About AMAG

AMAG is a biopharmaceutical company focused on developing and delivering important therapeutics, conducting clinical research in areas of unmet need and creating education and support programs for the patients and families we serve. Our currently marketed products support the health of patients in the areas of maternal and women’s health, anemia management and cancer supportive care. Through CBR®, we also help families to preserve newborn stem cells, which are used today in transplant medicine for certain cancers and blood, immune and metabolic disorders, and have the potential to play a valuable role in the ongoing development of regenerative medicine. For additional company information, please visit

About The Bowdoin Group

Founded in 1994, The Bowdoin Group is an award-winning executive search firm that specializes in leadership and strategic roles for a wide range of companies, from small firms building out their executive team to large firms sourcing talent for rapid market expansion. With deep expertise in BioPharma, Digital Health, FinTech and Financial Services, and Software, The Bowdoin Group is a leader in the Greater Boston area with capabilities to source talent and service companies globally.  The company’s service reputation earned it a ranking in the top 2% of the industry for client satisfaction.  Bowdoin is active in supporting Boston’s entrepreneurial ecosystem as well as several non-profit causes.

Visit us at and connect with us on LinkedIn, Twitter, and Facebook.

Lauren Lessard
Marketing and Communications Associate